Stable Isotope Labeled Bimagrumab Biosimilar – Anti-ACVR2A/ACVR2B mAb – Research Grade

Reference: PX-TA1315-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Description of Bimagrumab Biosimilar - Anti-ACVR2A/ACVR2B mAb - Research Grade

General information on Anti-ACVR2A/ACVR2B[Homo sapiens] (Bimagrumab) Monoclonal Antibody

Bimagrumab has been investigated for the treatment of Sarcopenia, Skeletal Muscle, Mechanical Ventilation, Sporadic Inclusion Body Myositis, and Sporadic Inclusion Body Myositis (sIBM).

Product nameStable Isotope Labeled Bimagrumab Biosimilar - Anti-ACVR2A/ACVR2B mAb - Research Grade
SourceCAS 1356922-05-8
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsBYM338
ReferencePX-TA1315-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-lambda
ClonalityMonoclonal Antibody
SourceCAS 1356922-05-8
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2
Isotopic Enrichment99%
Stability1 year

Reviews

There are no reviews yet.

Be the first to review “Stable Isotope Labeled Bimagrumab Biosimilar – Anti-ACVR2A/ACVR2B mAb – Research Grade”

Your email address will not be published.


1,500.00

OK

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us to order

+33 (0)3 90 20 54 70

Write us

Categories: